EPITOPE MAPPING OF HUMAN FACTOR-IX INHIBITOR ANTIBODIES

被引:7
作者
TAKAHASHI, I
MIZUMO, S
KAMIYA, T
TAKAMATSU, J
SAITO, H
机构
[1] AICHI BLOOD DIS RES FDN,NAGOYA,AICHI,JAPAN
[2] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 1,NAGOYA,AICHI 466,JAPAN
关键词
FACTOR IX; INHIBITOR; EPITOPE MAPPING; PEPTIDE; NEUTRALIZATION;
D O I
10.1111/j.1365-2141.1994.tb04992.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have determined the location of epitopes on the factor M for three haemophilia B inhibitor antibodies (HB-1, HB-3, HB-7) and a monoclonal anti-factor TX inhibitory antibody (designated 65-10). The main binding region of HB-1, HB-3 and HB-7 was (155)YVNSTEAETI(164) (residues 155-164), (167)NITQSTQSFN(176) and (156)VNSTEAETTI(164), respectively. The binding region of 65-10 was (168)ITQSTQSFNDFTRVV(182), which included the cleavage site ((180)R-V-181) for activation by factor XIa. By neutralization experiments using two peptides. (156)VNSTEAETI(164) and (167)NITQSTQSFN(176), the degree of neutralization of anti-factor TX IgG purified by protein A was determined. Neutralization of three antibodies, HB-1, HB-3 and HB-7, in the presence of 10mM of the peptides (156)VNSTEAETI(164) was 30.1%, 0% and 10.8%, respectively, and in the presence of 4 mM of (167)NITQSTQSFN(176) it was 0%, 13.5% and 17.3%, respectively. On the other hand, when plasmas of patients instead of purified IgG were used for neutralization, 10 mM of (156)VNSTEAETI(164) and 4 mM of (167)NITQSTQSFN(176) failed to neutralize the inhibitor in the plasmas.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 29 条
[1]  
ABILDGAARD CF, 1980, BLOOD, V56, P978
[2]   ANTIBODY-PROBED CONFORMATIONAL TRANSITIONS IN THE PROTEASE DOMAIN OF HUMAN FACTOR-IX UPON CALCIUM-BINDING AND ZYMOGEN ACTIVATION - PUTATIVE HIGH-AFFINITY CA2+-BINDING SITE IN THE PROTEASE DOMAIN [J].
BAJAJ, SP ;
SABHARWAL, AK ;
GORKA, J ;
BIRKTOFT, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (01) :152-156
[3]   EFFECT OF RECOMBINANT FACTOR-VIIA ON THE HEMOSTATIC DEFECT IN DOGS WITH HEMOPHILIA-A, HEMOPHILIA-B, AND VONWILLEBRAND DISEASE [J].
BRINKHOUS, KM ;
HEDNER, U ;
GARRIS, JB ;
DINESS, V ;
READ, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1382-1386
[4]   CG DINUCLEOTIDE TRANSITIONS IN THE FACTOR-IX GENE ACCOUNT FOR ABOUT HALF OF THE POINT MUTATIONS IN HEMOPHILIA-B PATIENTS - A SEATTLE SERIES [J].
CHEN, SH ;
ZHANG, M ;
LOVRIEN, EW ;
SCOTT, CR ;
THOMPSON, AR .
HUMAN GENETICS, 1991, 87 (02) :177-182
[5]  
CHEUNG WF, 1992, BLOOD, V80, pA229
[6]  
FRAZIER D, 1989, BLOOD, V74, P971
[7]   USE OF PEPTIDE-SYNTHESIS TO PROBE VIRAL-ANTIGENS FOR EPITOPES TO A RESOLUTION OF A SINGLE AMINO-ACID [J].
GEYSEN, HM ;
MELOEN, RH ;
BARTELING, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (13) :3998-4002
[8]  
GIANNELLI F, 1983, NATURE, V303, P181, DOI 10.1038/303181a0
[9]  
HANSSAN HJ, 1985, BLOOD, V66, P728
[10]  
Hedner U, 1990, Blood Coagul Fibrinolysis, V1, P307, DOI 10.1097/00001721-199008000-00009